Effect of montelukast on peripheral airflow obstruction in children with asthma

Annals of Allergy, Asthma and Immunology

Volumn 96, Issue 4, 2006, Pages 541-549

  Spahn, Joseph D ^a   Covar, Ronina A ^a   Jain, Neal ^a   Gleason, Melanie ^a   Shimamoto, Reed ^a   Szefler, Stanley J ^a   Gelfand, Erwin W ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; MONTELUKAST; NITRIC OXIDE; PREDNISONE; SALBUTAMOL;

ADOLESCENT; AFRICAN AMERICAN; AIRWAY CONDUCTANCE; AIRWAY OBSTRUCTION; AIRWAY RESISTANCE; ARTICLE; ASTHMA; BODY PLETHYSMOGRAPHY; CAUCASIAN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE DURATION; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG TOLERABILITY; DRUG WITHDRAWAL; EOSINOPHIL COUNT; EXPIRED AIR; FEMALE; FORCED EXPIRATORY VOLUME; HISPANIC; HUMAN; MALE; OSCILLOMETRY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESIDUAL VOLUME; SCHOOL CHILD; STATISTICAL ANALYSIS; TOTAL LUNG CAPACITY;

EID: 33645996731     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63548-X     Document Type: Article

References (38)

1. Kraft M, Djukanovic R, Wilson S, Holgate ST, Martin RJ. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med. 1996;154:1505-1510.
2. Kraft M, Djukanovic R, Wilson S, Holgate ST, Martin RJ. Lymphocyte and eosinophil influx into alveolar tissue in nocturnal asthma. Am J Respir Crit Care Med. 1999;159:228-234.
3. Wenzel SE, Szefler SJ, Leung DYM, Sloan SI, Rex MD, Martin RJ. Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med. 1997;156:737-743.
4. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics-2002. J Allergy Clin Immunol. 2002;110:S141-S219.
5. Spahn JD, Cherniack R, Paull K, Gelfand EW. Is the forced expiratory volume in one second the best measure of asthma severity in childhood asthma? Am J Respir Crit Care Med. 2004;169:784-786.
6. 1 is associated with risk of asthma attacks in a pediatric population. J Allergy Clin Immunol. 2001;107:61-67.
7. Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med. 2000;343:1054-1063.
8. Bacharier LB, Strunk RC, Mauger D, White D, Lemanske RF Jr, Sorkness CA. Classifying asthma severity in children: mismatch between symptoms, medication use, and lung function. Am J Respir Crit Care Med. 2004;170:426-432.
9. Jenkins HA, Cherniack RM, Szefler SJ, Covar R, Gelfand EW, Spahn JD. A comparison of the clinical characteristics of children and adults with severe asthma. Chest. 2003;124: 1318-1324.
10. Paull K, Covar R, Jain N, Gelfand E, Spahn J. Do NHLBI lung function criteria apply to children? a cross-sectional evaluation of childhood asthma at National Jewish Medical and Research Center 1999-2000. Pediatr Pulmonol. 2005;39:311-317.
11. Paull K, Cherniack R, Gelfand EW, Spahn JD. Evaluating elastic recoil of the lung in pediatric asthma. J Allergy Clin Immunol. 2004;113:5265.
12. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med. 1968;278:1355-1360.
13. Wagner EM, Liu MC, Weinmann GG, Permutt S, Bleecker ER. Peripheral lung resistance in normals and asthmatic subjects. Am Rev Respir Dis. 1990;141:584-588.
14. Martin RJ. Small airway and alveolar tissue changes in nocturnal asthma. Am J Respir Crit Care Med. 1998;157:S188-S190.
15. Wildhaber JH, Dore ND, Wilson JM, Devadason SG, LeSouef PN. Inhalation therapy in asthma: nebulizer or pressurized metered-dose inhaler with holding chamber? in vivo comparison of lung deposition in children. J Pediatr. 1999;135:28-33.
16. 11C]-triamcinolone acetonide. J Nucl Med. 2000;41:1603-1611.
17. Reiss TF, Chervinsky P, Dockhorn RJ, Shingo S, Seidenberg B, Edwards TB. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Arch Intern Med. 1998;158: 1213-1220.
18. Knorr B, Matz J, Bernstein JA, et al. Montelukast for chronic asthma in 6- to 14-year-old children. JAMA. 1998;279: 1181-1186.
19. Knorr B, Franchi LM, Bisgaard H, et al. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics. 2001;108:E48.
20. Villaran C, O'Neill SJ, Hebung A, et al. Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. J Allergy Clin Immunol. 1999;104:547-553.
21. Marotta A, Klinnert MD, Price MR, Larsen GL, Liu AH. Impulse oscillometry provides an effective measure of lung dysfunction in 4-year-old children at risk for persistent asthma. J Allergy Clin Immunol. 2003;112:317-322.
22. Silkoff PE, McClean PA, Slutsky AS, et al. Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. Am J Respir Crit Care Med. 1997; 155:260-267.
23. American Thoracic Society. Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children. Am J Respir Crit Care Med. 1999;160:2104-2117.
24. Cartwright GE. Diagnostic Laboratory Hematology. 4th ed. New York, NY: Grune & Stratton; 1968:48.
25. MacFarlane JCW, Cecil GW. Eosinophil counting: a modification of Pilot's method. BMJ. 1951;4741:1187-1189.
26. Spahn JD, Leung DYM, Surs W, Harbeck RJ, Nimmagadda S, Szefler SJ. Reduced glucocorticoid binding affinity in asthma is related to ongoing allergic inflammation. Am J Respir Crit Care Med. 1995;151:1709-1714.
27. Castile RG. Pulmonary function testing in children. In: Chernick V, Boat TF, eds. Kendig's Disorders of the Respiratory Tract in Children. 6th ed. 1998:196-214.
28. Pride NB. Forced oscillation techniques for measuring mechanical properties of the respiratory system. Thorax. 1992;47: 317-320.
29. Woolcock AJ. Effects of drugs on small airways. Am J Respir Crit Care Med. 1998;157:S203-S207.
30. Brutsche MH, Brutsche IC, Munavvar M, et al. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomized crossover study. Lancet. 2000;356:556-561.
31. Schuh S, Reisman J, Alshehri M, et al. A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma. N Engl J Med. 2000;343:689-694.
32. Bisgaard H, Loland L, Anhoj J. NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast. Am J Respir Crit Care Med. 1999;160:1227-1231.
33. Bratton DL, Lanz MJ, Miyazawa N, White CW, Silkoff PE. Exhaled nitric oxide before and after montelukast sodium therapy in school-age children with chronic asthma: a preliminary study. Pediatr Pulmonol. 1999;28:402-407.
34. Pizzichini E, Leff JA, Reiss TF, et al. Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial. Eur Respir J. 1999;14:12-18.
35. Spahn JD, Szefler SJ. Inhaled glucocorticoids. In: Martin RJ, Kraft M, eds. Combination Therapy for Asthma and COPD. New York, NY: Marcel Dekker; 2000:1-52.
36. Lenfant C, ed. Lung Biology in Health and Diseases Series; vol 145.
37. Malmstrom K, Rodriguez-Gomez G, Guerra J, et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma: a randomized trial. Ann Intern Med. 1999;130: 487-495.
38. Sekerel BE, Tuncer A, Saraclar Y, Adalioglu G. Inhaled budesonide reduces lung hyperinflation in children with asthma. Acta Paediatr. 1997;86:932-936.